Volgende

Automatisch afspelen

Clinical trial updates for CTCL: ARGX-110 and mogamulizumab

5 Bekeken • 08/09/23
Delen
insluiten
administrator
administrator
abonnees
0

Martine Bagot, MD, PhD, of the Saint Louis Hospital, Paris, France, discusses two clinical trials for cutaneous T-cell lymphoma (CTCL): the Phase I/II study (NCT01813539) assessing the role of ARGX-110, a CD70-directed monoclonal antibody, and the Phase III MAVORIC study (NCT01728805) examining the effect of mogamulizumab. Prof. Bagot speaks at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, on the safety, efficacy and tolerability of these treatments.

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen